Azora Therapeutics
Encino, US · Delaware corporation · 2 known investors
Clinical-stage biopharmaceutical company developing best-in-class aryl hydrocarbon receptor agonists.
Founders & leadership
MD
Matthew DavidsonExecutive
JS
Julie SaikiSecretary of the Issuer
Board
DB
Dennis BrownBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$8.3M disclosed across 2 rounds · 2021–2023
▶$581.4KraisedAug 2023 · 11 investors · PharmaceuticalsRule 506(b)
▶$581.4KraisedAug 2023 · 11 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Dennis BrownDirector
- Julie SaikiExecutive Officer, Director
- Matthew DavidsonExecutive Officer, Director
- Offering amount
- $596.4K
- Amount sold
- $581.4K
- First sale
- Aug 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7.7MraisedJun 2021 · 108 investors · PharmaceuticalsRule 506(b)
▶$7.7MraisedJun 2021 · 108 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Dennis BrownDirector
- Matt DavidsonExecutive Officer, Director
- Julie SaikiExecutive Officer, Director
- Offering amount
- $8.4M
- Amount sold
- $7.7M
- First sale
- Jun 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Azora Therapeutics do?
- Clinical-stage biopharmaceutical company developing best-in-class aryl hydrocarbon receptor agonists.
- Who are Azora Therapeutics's investors?
- Azora Therapeutics's investors include 7G BioVentures, Tarnagulla Ventures.
- How much funding has Azora Therapeutics raised?
- Azora Therapeutics has disclosed $8.3M raised across 2 rounds.
- Where is Azora Therapeutics headquartered?
- Azora Therapeutics is headquartered in Encino, US.